NCT00001035: The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections |
|
|
| Completed | 1 | 10 | US | Interferon alfa-2b, Zidovudine, Zalcitabine, Didanosine | National Institute of Allergy and Infectious Diseases (NIAID), Schering-Plough | HIV Infections, Hepatitis C | | 09/96 | | |
NCT01217359: Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling |
|
|
| Completed | 1 | 22 | US | Interferon Alfa-2b, Intron A | University of North Carolina, Chapel Hill, Tibotec Pharmaceutical Limited | Hepatitis C | 08/12 | 08/12 | | |
